Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$5.55 USD
-0.06 (-1.07%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $5.56 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/03/2024
Time: -- |
3/2024 | $-0.65 | -34.88% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.23 per share, beating the Zacks Consensus Estimate of $-0.52 per share. This reflects a positive earnings surprise of 55.77%. Look out for EDIT's next earnings release expected on May 03, 2024. For the next earning release, we expect the company to report earnings of -$0.65 per share, reflecting a year-over-year increase of 8.45%.
Earnings History
Price & Consensus
Zacks News for EDIT
Editas (EDIT) Q4 Earnings & Revenues Top Estimates, Stock Up
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services